Concise Review: Human Pluripotent Stem Cells to Produce Cell‐Based Cancer Immunotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1549-4918|36|2|134-145

ISSN： 1066-5099

Source： STEM CELLS, Vol.36, Iss.2, 2018-02, pp. : 134-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells

By  

STEM CELLS, Vol. 33, Iss. 9, 2015-09 ,pp. : 2643-2651

John Wiley & Sons Inc

Access to resources Recommend Favorite

Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology

By  

STEM CELLS, Vol. 1066-5099, Iss. 10, 2015-10 ,pp. : 2887-2892

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical‐scale purification of pluripotent stem cell derivatives for cell‐based therapies

By  

BIOTECHNOLOGY JOURNAL (ELECTRONIC), Vol. 10, Iss. 8, 2015-08 ,pp. : 1103-1114

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteomics-Based Analysis of Protein Complexes in Pluripotent Stem Cells and Cancer Biology

By Sudhir Putty-Reddy   Chen Chung-Hsuan  

International Journal of Molecular Sciences, Vol. 17, Iss. 3, 2016-03 ,pp. : 432-432

MDPI

Access to resources Recommend Favorite

Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond

By  

WILEY INTERDISCIPLINARY REVIEWS: RNA (ELECTRONIC), Vol. 6, Iss. 5, 2015-09 ,pp. : 471-499

John Wiley & Sons Inc

Access to resources Recommend Favorite